Vutrisiran 25mg/0.5ml solution for injection pre-filled syringes
NHS hospitals in England used £99,505,130 of indicative cost of Vutrisiran 25mg/0.5ml solution for injection pre-filled syringes in the 12 months to July 2026, about 0.4% of all hospital medicines spend. That is up 24.2% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Vutrisiran 25mg/0.5ml solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Vutrisiran 25mg/0.5ml solution for injection pre-filled syringes most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Royal Free London Nhs Foundation Trust | £98,546,506 |
| Univ Hpl B/Ham Nhs Foundation Trust | £958,624 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.